Big Pharma
Women’s Health and Customized Delivery Systems
Women’s Health and Customized Delivery Systems GELITA presents compelling solutions at Vitafoods Asia Bioactive Collagen Peptides support Women's Health (lifePR) (Eberbach, 09.09.2022) GELITA, the leading manufacturer of gelatin and collagen peptides, will be back at Vitafoods Asia in Bangkok on October 5-7 presenting its latest Bioactive Collagen Peptides solutions for women’s health and customized delivery systems with specific gelatins. Women’s health in the spotlight Because our live expectancy is constantly increasing, it is now less about adding years to your live but much more about adding live to your years. Means having a fulfilling live in health and good shape...
Hope for Hepatitis Patients as New Paper Presents Path to its Elimination
Hope for Hepatitis Patients as New Paper Presents Path to its Elimination A new World Economic Forum paper outlines steps for countries to tackle viral hepatitis, one of the world’s leading infectious killers An estimated 1.1 million people die from hepatitis B and C globally every year, even though effective treatments exist The paper uses Egypt as a case study – the country has gone from the world’s highest hepatitis infection rates to near elimination – to demonstrate how the disease can be defeated Read the report here Geneva, Switzerland, September 2022 – The World Economic Forum published a white...
Episurf Medical’s Episealer® Knee implants included in UK NICE guidelines
Episurf Medical’s Episealer® Knee implants included in UK NICE guidelines Wed, Aug 24, 2022 09:15 CET Report this content Episurf Medical (NASDAQ: EPIS B) today announces that the UK National Institute for Health and Care Excellence (NICE) has on August 24 published interventional procedures guidance on IPG734 Focal resurfacing implants to treat articular cartilage damage in the knee, where Episurf Medical’s Episealer® Knee implants are included. The publication follows a review of relevant documentation and stakeholder input, including patients and surgeons, that has been going on for several quarters. NICE guidelines are evidence-based recommendations for health and care in the...
New generation of corona vaccine shows promising results
New generation of corona vaccine shows promising results Researchers at Karolinska Institutet in Sweden are developing a coronavirus vaccine designed to be less sensitive to mutations and equipped for future strains. The vaccine showed promising results in mice in a newly published study in EMBO Molecular Medicine, and the researchers now hope to be able to take it to safety studies on humans. “This is a new generation of corona vaccine,” says Matti Sällberg, professor at the Department of Laboratory Medicine, Karolinska Institutet, and the study’s joint last author with Ali Mirazimi, adjunct professor at the same department. “The idea...
CS MEDICA A/S signs LoI with investor about a directed issue of 60 MDKK at a share price of DKK 31,50 per share
CS MEDICA A/S signs LoI with investor about a directed issue of 60 MDKK at a share price of DKK 31,50 per share CS MEDICA A/S (“CS Medica” or the “Company”) signs Letter Of Intent (LoI) with Heilongjiang FuYu ShengKun Textile Industry Co., Ltd regarding a directed issue of 60 MDKK at a share price of 31.50 DKK Following the company’s intensified discussion with potential investors, notified the 18th of august 2022, CS MEDICA A/S has signed a letter of intent with Heilongjiang FuYu ShengKun Textile Industry Co. (”new Investor”), regarding a directed issue of 1,904,762 shares in the Company...